Cargando…

Prevalence of Vitiligo Among Adults in the United States

IMPORTANCE: Vitiligo can have profound effects on patients and is often associated with other autoimmune comorbid conditions. It is important to understand the current prevalence of vitiligo, including diagnosed, undiagnosed, and subtypes (nonsegmental and segmental). OBJECTIVE: To estimate the poin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gandhi, Kavita, Ezzedine, Khaled, Anastassopoulos, Kathryn P., Patel, Reema, Sikirica, Vanja, Daniel, Shoshana R., Napatalung, Lynne, Yamaguchi, Yuji, Baik, Rebecca, Pandya, Amit G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600454/ https://www.ncbi.nlm.nih.gov/pubmed/34787670 http://dx.doi.org/10.1001/jamadermatol.2021.4724

Ejemplares similares

Prevalence of Vitiligo among Children and Adolescents in the United States
por: Patel, Reema, et al.
Publicado: (2023)

Diagnosed Prevalence and Incidence of Vitiligo in the United States: Analysis of Employer-Sponsored Insurance Claims
por: Ray, Markqayne, et al.
Publicado: (2023)

Comorbidity Burden Among Patients with Vitiligo in the United States: A Large-Scale Retrospective Claims Database Analysis
por: Ezzedine, Khaled, et al.
Publicado: (2023)

Psychosocial Effects of Vitiligo: A Systematic Literature Review
por: Ezzedine, Khaled, et al.
Publicado: (2021)

Patient Perspectives of the Social, Emotional and Functional Impact of Alopecia Areata: A Systematic Literature Review
por: Mostaghimi, Arash, et al.
Publicado: (2021)

Vitiligo prevalence and quality of life among adults in Europe, Japan and the USA
por: Bibeau, K., et al.
Publicado: (2022)

Vitiligo International Task force for an Agreed List of core data (VITAL): study protocol of a vitiligo core outcome set (COS) and contextual factors for clinical trials, registries, and clinical practice
por: van Geel, Nanja, et al.
Publicado: (2022)

Nail abnormalities in patients with vitiligo
por: Topal, Ilteris Oguz, et al.
Publicado: (2016)

Macrophage migration inhibitory factor as an incriminating agent in vitiligo
por: Farag, Azza Gaber Antar, et al.
Publicado: (2018)

Decreased levels of interleukin 27 in the serum of vitiligo patients()()
por: Hosseini, Saeed Malek, et al.
Publicado: (2020)

All-cause health care resource utilization and costs among adults with alopecia areata: A retrospective claims database study in the United States
por: Mostaghimi, Arash, et al.
Publicado: (2022)

Knowledge, beliefs, and perceptions of Turkish vitiligo patients regarding their condition
por: Topal, Ilteris Oguz, et al.
Publicado: (2016)

Prepubertal and postpubertal vitiligo: a multivariate comparative study in 375 patients
por: Khurrum, Huma, et al.
Publicado: (2017)

Recipient site preparation for epidermal graft in stable vitiligo by a special fraise()
por: Ebrahimi, Ali, et al.
Publicado: (2015)

Reliability and validity of the Vitiligo Signs of Activity Score (VSAS)
por: van Geel, N., et al.
Publicado: (2020)

Higher incidence of metabolic syndrome components in vitiligo patients: a prospective cross-sectional study()()
por: Tanacan, Efsun, et al.
Publicado: (2020)

A study of the association of glutathione S-transferase M1/T1 polymorphisms with susceptibility to vitiligo in Egyptian patients
por: Aly, Dalia Gamal, et al.
Publicado: (2018)

Evaluation of treatment response to autologous transplantation of noncultured melanocyte/keratinocyte cell suspension in patients with stable vitiligo
por: Ramos, Mariana Gontijo, et al.
Publicado: (2017)

Leucine-rich glioma inactivated 3: a novel keratinocyte-derived melanogenic cytokine in vitiligo patients
por: Farag, Azza Gaber Antar, et al.
Publicado: (2019)

Evaluation of skin expression profiles of patients with vitiligo treated with narrow-band UVB therapy by targeted RNA-seq
por: Ocampo-Candiani, Jorge, et al.
Publicado: (2018)

Clinical and Healthcare Resource Use Outcomes between Dual-plane and Prepectoral Techniques in Implant-based Breast Reconstruction: A Multicenter Retrospective Study
por: Bruno, James R., et al.
Publicado: (2023)

A case series pilot study on the combination of 5-aminolevulinic acid and photodynamic therapy (ALA-PDT) for treatment of vitiligo
por: Zhang, YunJie, et al.
Publicado: (2018)

Healthcare Utilization and Costs Among US Adolescents With Alopecia Areata
por: Ray, Markqayne, et al.
Publicado: (2022)

Prevalence, comorbidities, and treatment patterns of Japanese patients with alopecia areata: A descriptive study using Japan medical data center claims database
por: Campos‐Alberto, Eduardo, et al.
Publicado: (2022)

Translation, cross-cultural adaptation and validation of the vitiligo-specific health-related quality of life instrument (VitiQoL) into Brazilian Portuguese
por: Boza, Juliana Catucci, et al.
Publicado: (2015)

Expert opinion about laser and intense pulsed light (IPL)-induced leukoderma or vitiligo: a cross-sectional survey study
por: Post, Nicoline F., et al.
Publicado: (2023)

A Large Cross-Sectional Survey Study of the Prevalence of Alopecia Areata in the United States
por: Benigno, Michael, et al.
Publicado: (2020)

An Ecological Study Indicates the Importance of Ultraviolet A Protection in Sunscreens
por: MERHI, Samar, et al.
Publicado: (2021)

Overview of alopecia areata for managed care and payer stakeholders in the United States
por: King, Brett, et al.
Publicado: (2023)

Common variants in FOXP1 are associated with generalized vitiligo
por: Jin, Ying, et al.
Publicado: (2010)

Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder – a systematic literature review
por: Gajria, Kavita, et al.
Publicado: (2014)

Relationship of macrophage migration inhibitory factor levels in PBMCs, lesional skin and serum with disease severity and activity in vitiligo vulgaris
por: Ma, Lei, et al.
Publicado: (2013)

Can Systemically Generated Reactive Oxygen Species Help to Monitor Disease Activity in Generalized Vitiligo? A Pilot Study
por: Pradhan, Richeek, et al.
Publicado: (2014)

Early-onset autoimmune vitiligo associated with an enhancer variant haplotype that upregulates class II HLA expression
por: Jin, Ying, et al.
Publicado: (2019)

Preferences for Attention-Deficit/Hyperactivity Disorder (ADHD) Non-Stimulant Treatment Characteristics Among Children and Adolescents With ADHD and Their Caregivers
por: Flood, Emuella, et al.
Publicado: (2016)

Chemical Vitiligo: A Subset of Vitiligo
por: Ghosh, Sanjay
Publicado: (2020)

Single-Hair Follicular Unit Transplant for Stable Vitiligo
por: Kumaresan, Muthuvel
Publicado: (2011)

Follicular Unit Extraction as a Therapeutic Option for Vitiligo
por: Sacchidanand, S, et al.
Publicado: (2013)

Mental Health and Psychosocial Quality-of-Life Burden Among Patients With Vitiligo: Findings From the Global VALIANT Study
por: Bibeau, Kristen, et al.
Publicado: (2023)

Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD
por: Lachaine, Jean, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_m3mum6i9947u4dei1p6n9jlp7s